Florence A. Aeschlimann

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease

Florence A. Aeschlimann, Ezgi Deniz Batu, Scott Canna et al. · Annals of the Rheumatic Diseases · 2018 · 231 citations

Life Sciences, Genetics, Molecular Genetics +17

JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study

Tom Le Voyer, Cyril Gitiaux, François‐Jérôme Authier et al. · Lara D. Veeken · 2021 · 81 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Childhood Takayasu arteritis: disease course and response to therapy

Florence A. Aeschlimann, Simon Eng, Shehla Sheikh et al. · Arthritis Research & Therapy · 2017 · 78 citations · Full text

Medicine, Child Health, Pediatrics +13

Presentation and Disease Course of Childhood‐Onset Versus Adult‐Onset Takayasu Arteritis

Florence A. Aeschlimann, Lillian Barra, Roaa Alsolaimani et al. · Arthritis & Rheumatology · 2018 · 60 citations

Medicine, Internal Medicine, Pediatrics +13